[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK399282A - Fremgangsmaade til fremstilling af cephalosporinderivater - Google Patents

Fremgangsmaade til fremstilling af cephalosporinderivater Download PDF

Info

Publication number
DK399282A
DK399282A DK399282A DK399282A DK399282A DK 399282 A DK399282 A DK 399282A DK 399282 A DK399282 A DK 399282A DK 399282 A DK399282 A DK 399282A DK 399282 A DK399282 A DK 399282A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
cephalosporine derivatives
cephalosporine
derivatives
Prior art date
Application number
DK399282A
Other languages
Danish (da)
English (en)
Inventor
William Henry Walker Lunn
Robert Theodore Vasileff
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK399282A publication Critical patent/DK399282A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK399282A 1981-09-08 1982-09-07 Fremgangsmaade til fremstilling af cephalosporinderivater DK399282A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30035781A 1981-09-08 1981-09-08
US34062882A 1982-01-19 1982-01-19

Publications (1)

Publication Number Publication Date
DK399282A true DK399282A (da) 1983-03-09

Family

ID=26971737

Family Applications (1)

Application Number Title Priority Date Filing Date
DK399282A DK399282A (da) 1981-09-08 1982-09-07 Fremgangsmaade til fremstilling af cephalosporinderivater

Country Status (17)

Country Link
EP (1) EP0074268A3 (fr)
KR (1) KR840001585A (fr)
CS (1) CS232735B2 (fr)
DD (1) DD209633A5 (fr)
DK (1) DK399282A (fr)
ES (2) ES8404361A1 (fr)
FI (1) FI823088L (fr)
GB (1) GB2105719A (fr)
GR (1) GR76701B (fr)
HU (1) HU187575B (fr)
IL (1) IL66726A0 (fr)
NZ (1) NZ201833A (fr)
PH (1) PH19756A (fr)
PL (1) PL238158A1 (fr)
PT (1) PT75518B (fr)
RO (1) RO84456B (fr)
SU (1) SU1169542A3 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE30724T1 (de) * 1982-06-28 1987-11-15 Bristol Myers Co Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.
US4480098A (en) * 1982-11-12 1984-10-30 Eli Lilly And Company Preparation of alkali metal thieno(furo)pyridines
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
EP0137442A3 (fr) * 1983-10-08 1986-01-15 Hoechst Aktiengesellschaft Dérivés de céphalosporine et procédé pour leur préparation
GB2148289B (en) * 1983-10-17 1987-09-23 Lilly Co Eli 3-bicyclicpyridinium-methyl cephalosporins
US4868173A (en) * 1984-11-20 1989-09-19 Ici Pharma Cephalosporin derivatives
EP0187456A1 (fr) * 1984-11-29 1986-07-16 Ici Pharma Dérivés de céphalosporine
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
GB8626245D0 (en) * 1985-11-27 1986-12-03 Ici Pharma Cephalosporin compounds
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US4918067A (en) * 1986-07-24 1990-04-17 Beecham Group P.L.C. Heterocyclic substituted penicillin antibiotics
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
MXPA02007719A (es) * 2000-02-10 2002-10-11 Upjohn Co Tioamidas de oxazolidinona con sustituyentes de piperazina y amida.
DE602004028111D1 (de) 2003-04-16 2010-08-26 Sandoz Ag Verfahren zur herstellung von cefepim
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DE2715385A1 (de) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
FR2440738A1 (fr) * 1978-11-13 1980-06-06 Parcor Medicament a base de derives des thieno (2,3-c) et (3,2-c) pyridines
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"

Also Published As

Publication number Publication date
GR76701B (fr) 1984-08-29
ES527763A0 (es) 1985-05-16
EP0074268A3 (fr) 1984-05-23
PH19756A (en) 1986-06-26
ES515548A0 (es) 1984-04-16
RO84456A (fr) 1984-06-21
HU187575B (en) 1986-01-28
CS650582A2 (en) 1984-06-18
PL238158A1 (en) 1984-11-19
ES8404361A1 (es) 1984-04-16
CS232735B2 (en) 1985-02-14
SU1169542A3 (ru) 1985-07-23
ES8505374A1 (es) 1985-05-16
FI823088A0 (fi) 1982-09-07
EP0074268A2 (fr) 1983-03-16
NZ201833A (en) 1985-09-13
IL66726A0 (en) 1982-12-31
FI823088L (fi) 1983-03-09
PT75518A (en) 1982-10-01
DD209633A5 (de) 1984-05-16
GB2105719A (en) 1983-03-30
RO84456B (ro) 1984-08-30
KR840001585A (ko) 1984-05-07
PT75518B (en) 1985-11-12

Similar Documents

Publication Publication Date Title
DK163243C (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK112582A (da) Fremgangsmaade til fremstilling af triazolonderivater
DK66582A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK301383A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK95383A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK399282A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK241883A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK86283A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK323083D0 (da) Fremgangsmade til fremstilling af 19-thio-androstanderivater
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK53780A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK261883A (da) Fremgangsmaade til fremstilling af prostaglandin-d-derivater
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK317283D0 (da) Fremgangsmade til fremstilling af thiadiazolderivater
DK375882A (da) Fremgangsmaade til fremstilling af benzisoxazolderivater
DK396482A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK507282A (da) Fremgangsmaade til fremstilling af azinorifamycin forbindelser
DK406579A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK70482A (da) Fremgangsmaade til fremstilling af diazolderivater
DK133081A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK272582A (da) Fremgangsmaade til fremstilling af cephalosporinderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment